tiprankstipranks
Astec Lifesciences Limited (IN:ASTEC)
:ASTEC
India Market

Astec Lifesciences Limited (ASTEC) Price & Analysis

Compare
1 Followers

ASTEC Stock Chart & Stats

₹703.50
-₹43.60(-3.76%)
At close: 4:00 PM EST
₹703.50
-₹43.60(-3.76%)

Bulls Say, Bears Say

Bulls Say
Vertically Integrated Product MixAstec’s business spans manufacture of technical actives, key intermediates and finished formulations, giving diversified revenue channels across the crop-protection value chain. This vertical exposure supports long-term customer stickiness, margin capture opportunities and resilience to single-product demand shocks.
Essential Industry ExposureOperating in agricultural inputs ties Astec to structural, non-discretionary demand driven by global food production and crop protection needs. Such secular demand underpins multi-month to multi-year revenue stability and supports long-term capacity utilization and investment planning despite cyclical swings.
Positive Shareholder Equity BufferMaintaining positive equity provides a tangible capital buffer that supports continued operations and creditor confidence. Over time this cushion can enable refinancing, asset-backed borrowing or equity raises on better terms versus firms with negative equity, improving survivability through downturns.
Bears Say
Declining Revenue And Negative MarginsSustained revenue decline and erosion of gross and net margins indicate structural pricing or demand issues, or rising input and operating costs. Persistently negative margins undermine retained earnings, restrict reinvestment capacity, and make margin recovery harder absent clear product or price improvements.
Rising Leverage And Weakening Equity RatioAn increasing debt burden and falling equity ratio raise refinancing, interest and covenant risks. Over a 2–6 month horizon this reduces financial flexibility to fund operations or capex, elevates default risk in stress scenarios, and can force costly deleveraging steps that impair growth initiatives.
Negative Operating And Free Cash FlowConsistent negative operating and free cash flow show the business struggles to convert reported performance into cash. This impairs ability to service debt, invest in efficiency or fund working capital organically, increasing dependence on external financing and dilutive capital raises over the medium term.

Astec Lifesciences Limited News

ASTEC FAQ

What was Astec Lifesciences Limited’s price range in the past 12 months?
Astec Lifesciences Limited lowest stock price was ₹512.35 and its highest was ₹990.88 in the past 12 months.
    What is Astec Lifesciences Limited’s market cap?
    Astec Lifesciences Limited’s market cap is ₹13.01B.
      When is Astec Lifesciences Limited’s upcoming earnings report date?
      Astec Lifesciences Limited’s upcoming earnings report date is May 06, 2026 which is in 38 days.
        How were Astec Lifesciences Limited’s earnings last quarter?
        Astec Lifesciences Limited released its earnings results on Jan 30, 2026. The company reported -₹7.04 earnings per share for the quarter, missing the consensus estimate of -₹6.3 by -₹0.74.
          Is Astec Lifesciences Limited overvalued?
          According to Wall Street analysts Astec Lifesciences Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Astec Lifesciences Limited pay dividends?
            Astec Lifesciences Limited pays a Annually dividend of ₹1.5 which represents an annual dividend yield of N/A. See more information on Astec Lifesciences Limited dividends here
              What is Astec Lifesciences Limited’s EPS estimate?
              Astec Lifesciences Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Astec Lifesciences Limited have?
              Astec Lifesciences Limited has 22,282,238 shares outstanding.
                What happened to Astec Lifesciences Limited’s price movement after its last earnings report?
                Astec Lifesciences Limited reported an EPS of -₹7.04 in its last earnings report, missing expectations of -₹6.3. Following the earnings report the stock price went down -0.243%.
                  Which hedge fund is a major shareholder of Astec Lifesciences Limited?
                  Currently, no hedge funds are holding shares in IN:ASTEC
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Astec Lifesciences Limited

                    Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

                    Astec Lifesciences Limited (ASTEC) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Heranba Industries Limited
                    IG Petrochemicals Ltd.
                    IOL Chemicals & Pharmaceuticals Ltd.
                    Punjab Chemicals & Crop Protection Ltd.
                    Uniphos Enterprises Limited
                    Popular Stocks